Literature DB >> 23116108

Engineered inorganic nanoparticles for drug delivery applications.

Isaac Ojea-Jiménez1, Joan Comenge, Lorena García-Fernández, Zoë A Megson, Eudald Casals, Victor F Puntes.   

Abstract

Inorganic nanoparticles (NPs) currently have immense potential as drug delivery vectors due to their unique physicochemical properties such as high surface area per unit volume, their optical and magnetic uniqueness and the ability to be functionalized with a large number of ligands to enhance their affinity towards target molecules. These features, together with the therapeutic activity of some drugs, render the combination of these two entities (NP-drug) as an attractive alternative in the area of drug delivery. One of the major advantages of these conjugates is the possibility to have a local delivery of the drug, thus reducing systemic side effects and enabling a higher efficiency of the therapeutic molecule. This review highlights the direct implications of nanoscale particles in the development of drug delivery systems. In more detail, it is also remarked the extensive use of inorganic NPs for targeted cancer therapies. As the range of nanoparticles and their applications continues to increase, human safety concerns are gaining importance, which makes it necessary to better understand the potential toxicity hazards of these materials.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23116108     DOI: 10.2174/13892002113149990008

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.408


  12 in total

Review 1.  Optical assays based on colloidal inorganic nanoparticles.

Authors:  Amir Ghasemi; Navid Rabiee; Sepideh Ahmadi; Shabnam Hashemzadeh; Farshad Lolasi; Mahnaz Bozorgomid; Alireza Kalbasi; Behzad Nasseri; Amin Shiralizadeh Dezfuli; Amir Reza Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Analyst       Date:  2018-06-20       Impact factor: 4.616

Review 2.  Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential.

Authors:  Anil B Jindal
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 3.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

4.  A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.

Authors:  Jing Wang; Jayanta Bhattacharyya; Eric Mastria; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2017-05-30       Impact factor: 9.776

Review 5.  Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.

Authors:  Kazuki Sawamoto; J Víctor Álvarez; Angélica María Herreño; Francisco J Otero-Espinar; Maria L Couce; Carlos J Alméciga-Díaz; Shunji Tomatsu
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

Review 6.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

Review 7.  Nanotechnology for the treatment of melanoma skin cancer.

Authors:  Lucas B Naves; Chetna Dhand; Jayarama Reddy Venugopal; Lakshminarayanan Rajamani; Seeram Ramakrishna; Luis Almeida
Journal:  Prog Biomater       Date:  2017-03-16

8.  Enhanced thermal effect using magnetic nano-particles during high-intensity focused ultrasound.

Authors:  Surendra Balaji Devarakonda; Matthew R Myers; Dushyanth Giridhar; Seyed Ahmad Reza Dibaji; Rupak Kumar Banerjee
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 9.  Drug Carrier for Photodynamic Cancer Therapy.

Authors:  Tilahun Ayane Debele; Sydney Peng; Hsieh-Chih Tsai
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

10.  Cell-Penetrating CaCO₃ Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma.

Authors:  Viviana Vergaro; Monica Civallero; Cinzia Citti; Maria Cosenza; Francesca Baldassarre; Giuseppe Cannazza; Samantha Pozzi; Stefano Sacchi; Francesco Paolo Fanizzi; Giuseppe Ciccarella
Journal:  Cancers (Basel)       Date:  2018-01-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.